The 2016 recipients of Lau grants

The Ming Wai Lau Centre for Reparative Medicine announces the first Lau grants to six group leaders at Karolinska Institutet. 

The Ming Wai Lau Centre for Reparative Medicine has the pleasure of announcing the names of the first Lau grant recipients at Karolinska Institutet. The Lau grants have been established to support world-leading research in regenerative medicine performed at Karolinska Institutet and to deepen existing and/or establishing new research partnerships with top universities in Hong Kong and China.

The steering group of the Ming Wai Lau Centre for Reparative Medicine has decided to award the following:

Gonçalo Castelo-Branco, Department of Medical Biochemistry and Biophysics
Modulating the epigenetic state of oligodendrocyte lineage cells to induce remyelination in multiple sclerosis

Simon Elsässer, Department of Medical Biochemistry and Biophysics
Function of short peptides encoded by sORFs (sPEPs)

Christian Göritz, Department of Cell and Molecular Biology
Central Nervous System Scarring and Repair

Francois Lallemend, Department of Neuroscience
Genetic control of neuronal survival: implications for new cancer therapies

Ning Xu Landén, Department of Medicine Solna
Regulatory RNAs in wound-edge keratinocytes: new perspectives towards treating chronic wounds

Fredrik Lanner, Department of Clinical Science, Intervention and Technology
Pluripotency, embryonic stem cells and regenerative medicine

They are awarded SEK 1.6 million each per year, for three years.

Facts on Lau grants

  • Lau grants are designed to support group leaders at KI at the stage where they are consolidating their own independent research.
  • Eligible to apply were group leaders employed by KI with up to 15 years of experience since completion of PhD (or equivalent degree) and scientific track record showing great promise and with several important publications without the participation of their PhD supervisor.
  • Researchers active within all fields relevant to regenerative medicine could apply, including developmental biology, stem cell research, biomedical engineering, and relevant technologies.
  • Evaluation was done by peer review by international experts outside of KI, on the basis of scientific excellence of the researcher’s track record and research proposal as well as the enhancement of collaboration with Hong Kong and Chinese scientific communities.
  • Research under this grant must be conducted at KI.
  • Decision was announced on 22 September 2016.
GrantRegenerative MedicineStem Cell Biology